Ignite Creation Date:
2025-12-24 @ 4:41 PM
Ignite Modification Date:
2025-12-24 @ 4:41 PM
Study NCT ID:
NCT06751966
Status:
RECRUITING
Last Update Posted:
2024-12-30
First Post:
2024-12-20
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
Sponsor:
The First Affiliated Hospital of Nanchang University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-20
First Submit QC Date:
None
Study First Post Date:
2024-12-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-27
Last Update Post Date:
2024-12-30
Last Update Post Date Type:
ACTUAL